Herb-written content.
President Trump’s December 18, 2025 executive order reclassifying marijuana from Schedule I to Schedule III marks a historic shift in federal drug policy—but it does not make weed legal. Cannabis remains federally prohibited, even as tax relief, medical research access, and limited CBD coverage signal meaningful changes for patients, businesses, and consumers.
President Trump’s December 18, 2025 executive order to reclassify marijuana from Schedule I to Schedule III marks the biggest shift in federal cannabis policy in over 50 years. While the move doesn’t legalize marijuana, it reshapes research, taxes, banking access, and medical recognition—changing what cannabis consumers, patients, and dispensaries can expect moving forward.
President Trump’s December 18, 2025 executive order to reclassify marijuana from Schedule I to Schedule III marks a historic shift in U.S. cannabis policy—but it also comes with important limits and misconceptions. This guide explains what Schedule III classification actually means, how it changes taxes, research, and medical recognition, and what cannabis users and patients should realistically expect as federal agencies implement the policy.